G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Market Cap	2.27B -28.9%
Revenue (ttm)	311.78M +37.9%
Net Income	143.10M +60.4%
EPS	2.24 +60.1%
Shares Out	63.72M
PE Ratio	15.86
Forward PE	n/a
Dividend	0.70 (1.95%)
Ex-Dividend Date	Jul 29, 2025

Volume	16,362
Average Volume	43,144
Open	35.50
Previous Close	35.55
Day's Range	35.50 - 35.50
52-Week Range	35.50 - 56.60
Beta	-0.86
RSI	17.22
Earnings Date	Mar 19, 2026

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products in Taiwan. It offers Hepanamin capsules; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 39
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.